CEACAM5 and gastric adenocarcinoma: As a specific NETs biomarker, serum NE-DNA showed better diagnostic efficiency compared with other common clinical biomarkers in gastric Adenocarcinoma, like carbohydrate antigen 19–9 (CA19-9) and carcinoembryonic antigen (CEA).